Insider filing · KYMR
Pamela Esposito
Director
profile →
Kymera Therapeutics, Inc.
KYMR · Healthcare · 58 filings in 24 months
ticker →
Pamela Esposito sold $2.2M of Kymera Therapeutics (KYMR)
Executed Dec 17 2025, disclosed Dec 17 2025, the same day.
Value, as filed
$2.2M
26,563 sh across 3 lots
Executed
Dec 17 2025
the trade date, as filed
Disclosed
Dec 17 2025
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
PEPamela Esposito (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $2.2M of KYMR (26,563 sh across 3 lots, as filed), executed Dec 17 2025.
The name
KYMRHealthcare · Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Pamela Esposito in KYMR
KYMRSALE
Kymera Therapeutics, Inc.
$165K1,900 sh × $87.06
Exec Feb 20
Filed Feb 20 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $333K
4,900 sh × $67.99
Exec Jan 20
Filed Jan 20 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $245K
5,000 sh × $49.04
Exec Jun 3 2025
Filed Jun 3 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $122K
2,500 sh × $49.00
Exec Dec 2 2024
Filed Dec 2 2024 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $652K
13,500 sh across 2 lots
Exec Sep 17 2024
Filed Sep 17 2024 · 5:30 PM ET